LOC646471 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.312800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.170000E-01
Normal-vs-Stage2
3.307200E-01
Normal-vs-Stage3
2.014800E-01
Normal-vs-Stage4
3.203600E-01
Stage1-vs-Stage2
1.833570E-01
Stage1-vs-Stage3
1.240750E-01
Stage1-vs-Stage4
7.651600E-01
Stage2-vs-Stage3
1.087790E-01
Stage2-vs-Stage4
5.533600E-01
Stage3-vs-Stage4
8.230100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.424600E-01
Normal-vs-AfricanAmerican
1.241380E-01
Normal-vs-Asian
3.026000E-02
Caucasian-vs-AfricanAmerican
5.393600E-01
Caucasian-vs-Asian
1.859620E-01
AfricanAmerican-vs-Asian
7.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.339400E-01
Normal-vs-Female
2.024300E-02
Male-vs-Female
9.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.190000E-01
Normal-vs-Age(41-60Yrs)
3.817000E-01
Normal-vs-Age(61-80Yrs)
3.117600E-01
Normal-vs-Age(81-100Yrs)
3.040100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.038200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.333600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.022240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.166200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.216500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.239000E-01
Normal-vs-Daily Drinker
2.379600E-02
Normal-vs-Weekly Drinker
6.631700E-02
Normal-vs-Occasional Drinker
1.778790E-01
Normal-vs-Social Drinker
1.460950E-01
Non Drinker-vs-Daily Drinker
6.122200E-01
Non Drinker-vs-Weekly Drinker
9.384000E-01
Non Drinker-vs-Occasional Drinker
3.797600E-01
Non Drinker-vs-Social Drinker
2.114000E-01
Daily Drinker-vs-Weekly Drinker
6.593000E-01
Daily Drinker-vs-Occasional Drinker
2.362200E-01
Daily Drinker-vs-Social Drinker
1.537960E-01
Weekly Drinker-vs-Occasional Drinker
5.061000E-01
Weekly Drinker-vs-Social Drinker
3.801400E-01
Occasional Drinker-vs-Social Drinker
8.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.639020E-01
Normal-vs-Grade 2
4.178000E-02
Normal-vs-Grade 3
3.320500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.255600E-01
Grade 1-vs-Grade 3
7.522600E-01
Grade 1-vs-Grade 4
1.639020E-01
Grade 2-vs-Grade 3
9.703800E-01
Grade 2-vs-Grade 4
4.178000E-02
Grade 3-vs-Grade 4
3.320500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.969600E-01
Normal-vs-NonDiabetic
3.286800E-01
Diabetic-vs-NonDiabetic
4.116200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.005000E-01
Normal-vs-NoPancreatitis
3.136800E-01
Pancreatitis-vs-NoPancreatitis
6.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.092400E-02
Normal-vs-N1
3.180600E-01
N0-vs-N1
4.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.269200E-01
Normal-vs-TP53-NonMutant
4.226600E-01
TP53-Mutant-vs-TP53-NonMutant
1.118030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
